Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Current Deferred Revenue (2020 - 2025)

Rapid Micro Biosystems (RPID) has disclosed Current Deferred Revenue for 6 consecutive years, with $4.7 million as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 28.78% to $4.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.7 million through Dec 2025, down 28.78% year-over-year, with the annual reading at $4.7 million for FY2025, 28.78% down from the prior year.
  • Current Deferred Revenue hit $4.7 million in Q4 2025 for Rapid Micro Biosystems, down from $5.1 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $6.6 million in Q4 2024 to a low of $3.3 million in Q4 2021.
  • Historically, Current Deferred Revenue has averaged $4.9 million across 5 years, with a median of $4.7 million in 2022.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 42.61% in 2022 and later dropped 28.78% in 2025.
  • Year by year, Current Deferred Revenue stood at $3.3 million in 2021, then soared by 42.61% to $4.7 million in 2022, then rose by 26.94% to $6.0 million in 2023, then rose by 10.46% to $6.6 million in 2024, then decreased by 28.78% to $4.7 million in 2025.
  • Business Quant data shows Current Deferred Revenue for RPID at $4.7 million in Q4 2025, $5.1 million in Q3 2025, and $6.1 million in Q2 2025.